The CTI Coaching Acceptance Commission has selected the RetinAI project to continue the process to obtaining the CTI Start-up Label. The CTI Start-up Label is a certificate of quality, sustainability, and credibility for investors, and favors successful market entry.
RetinAI will be participating in the Swiss AI Day: EmPOWER your Business, taking place on June 14th in Bern, and featuring top speakers in finance, insurance, healthcare, life sciences and research in AI. Don't miss the date and register now!
RetinAI has been awarded a Swiss non-dilutive public grant from the Swiss Commission for Technology and Innovation (CTI). The project size is close to CHF 1 Mil. and will develop over 24 months in collaboration with the OTL Group (ARTORG Center, UniBern).
Our project for bringing AI to Ophthalmology is among the 25 selected by the Jury of Venture, an initiative of ETHZ, McKinsey & Company CH, Knecht Holding, CTI & EPFL. On June 19th RetinAI will compete at the Venture Investor Day in Zurich for a cash price for start-ups in CH.
RetinAI + UniBern's collaboration on Optical Coherence Tomography (OCT) has outcome in a publication in the prestigious conference MICCAI'2017. Meet the RetinAI team in Quebec this September and have some discussions about Machine Learning in Ophthalmology.
Our team members travelled to the American Research in Vision and Ophthalmology (ARVO) conference 2017, in Baltimore, to present their products in the field of OCT image analisys and Fundus Imaging. Many new collaborations coming along after this week!
22 startups competed on the 2017 Startup Champions Seed Night at EPFL, a showcase of start-ups from a large range of industries. +450 attendees and an intensive networking session followed, getting ready for Venture Leaders Life Sciences Boston.
RetinAI among the 10 new Swiss Life Science startups selected by the venture leaders Life Science program’s jury to participate in this year’s high powered, one week investors and business roadshow in Boston, co-organized by Swissnex Boston and VentureLab.
RetinAI in collaboration with the OTL (ARTORG Center, UniBern) recently received a Swiss grant to bring forward the study of ocular diseases such as Age-Related Macular Degeneration (AMD), Diabetic Retinopathy (DR) and Glaucoma.
The RetinAI team got a 10'000.- CHF price for their startup idea of empowering eye care professionals and patients using machine learning and medical imaging in ophthalmology. The team is getting ready for the Venture Kick Phase II early this summer.
Several submissions from the RetinAI team to MICCAI 2017. Hopefully meeting everybody in Quebec!
RetinAI Medical attended to the Spirit of Bern as one of the start-up of reference in the Bernse region.
RetinAI Medical has been selected to continue to the next phase of CTI Coaching, an initiative proposed by the swiss goverment to support promising start-ups in a variety of innovative fields.
Every two years, Ypsomed organizes a start-up competition to attract the attention of the most interesting start-ups in the region of Bern.
Our new approach for achieving human level performance in the evaluation of AMD in OCT scans using convolutional neural network (CNNs) is out!